- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07300332
Bewegungstraining und Vitamin-D-Stoffwechsel (Hybri-D)
Die Auswirkung von Hybrid-Hochintensitäts-Intervalltraining auf den Vitamin-D-Stoffwechsel bei Erwachsenen mit Übergewicht/Adipositas
The prevalence of Vitamin D deficiency is significantly higher in adults with overweight/obesity compared to those with normal body mass index (BMI). The "entrapment" of Vitamin D in adipose tissue due to impaired lipolytic stimulation and/or adipose tissue dysfunction has been proposed as the driving mechanism. Exercise training has been proposed as a promising strategy to increase mobilization of Vitamin D from adipose tissue, given its well described role in stimulating lipolysis. Indeed, a recent study revealed that participation in moderate-intensity cardiovascular type exercise over winter can mitigate the decline in 25-hydroxyvitamin D [25(OH)D] in adults with overweight/obesity, independent of weight loss. The aim of this study is to investigate the impact of hybrid-type high-intensity interval training over winter on vitamin D metabolism, in adults with overweight/obesity.
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Thirty adults with overweight/obesity (both males and females) who will meet the inclusion criteria will be randomly assigned to either an Exercise group (n=15) or a Control group (n=15). The Exercise group will participate in three hybrid-type high-intensity interval training sessions per week over a 12-week period, while receiving a balanced diet. The Control group will receive a balanced diet but will not participate in exercise training. Both groups will provide a resting blood sample and undergo assessment of their body composition (via bioelectrical impedance analysis), daily dietary intake (via dietary recalls) and physical activity level (via accelerometry) at baseline (prior to intervention), 6 weeks and 12 weeks.
Studientyp
Einschreibung (Geschätzt)
Phase
- Unzutreffend
Kontakte und Standorte
Studienkontakt
- Name: Dimitrios Draganidis, PhD
- Telefonnummer: +302431047078
- E-Mail: ddraganidis@uth.gr
Studieren Sie die Kontaktsicherung
- Name: Ioannis G Fatouros, PhD
- Telefonnummer: 2431047047
- E-Mail: ifatouros@uth.gr
Studienorte
-
-
Karyes
-
Trikala, Karyes, Griechenland, 42100
- Rekrutierung
- Department of Physical Education and Sport Science, University of Thessaly
-
Kontakt:
- Ioannis G Fatouros, PhD
- Telefonnummer: 2431047047
- E-Mail: ifatouros@uth.gr
-
Kontakt:
- Athanasios Z Jamurtas, PhD
- Telefonnummer: 2431047054
- E-Mail: ajamurt@uth.gr
-
Unterermittler:
- Eytychia Giouvri, BSc
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- BMI = 25-35 kg/m2
- Absence of musculoskeletal injuries
- Absence of chronic health-related complications
- Non-smokers
Exclusion Criteria:
- Consumption of Vitamin D supplements
- Consumption of anti-inflammatory drugs, statins and/or steroids
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Sonstiges
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Keine (Offenes Etikett)
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Exercise group
Exercise group will participate in three hybrid-type high-intensity interval training sessions per week over a 12-week period, while receiving a balanced diet |
Receive a balanced diet and participate in three hybrid-type high-intensity interval training sessions per week over a 12-week period |
|
Aktiver Komparator: Control group
Control group will receive a balanced diet but will not participate in exercise training |
Receive a balanced diet but abstain from any type of exercise training |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in 25-hydroxyvitamin D concentration
Zeitfenster: At baseline, 6 weeks and 12 weeks
|
25-OH-VD will be quantitatively determined in serum |
At baseline, 6 weeks and 12 weeks
|
|
Change in plasma Vitamin D binding protein concentration
Zeitfenster: At baseline, 6 weeks and 12 weeks
|
Vitamin D binding protein concentration will be determined in plasma |
At baseline, 6 weeks and 12 weeks
|
|
Change in calcium concentration
Zeitfenster: At baseline, 6 weeks and 12 weeks
|
Calcium concentration will be determined in serum |
At baseline, 6 weeks and 12 weeks
|
|
Change in albumin concentration
Zeitfenster: At baseline, 6 weeks and 12 weeks
|
Albumin concentration will be determined in serum |
At baseline, 6 weeks and 12 weeks
|
|
Change in aspartate aminotransferase (SGOT) concentration
Zeitfenster: At baseline, 6 weeks and 12 weeks
|
SGOT concentration will be determined in serum on a Clinical Chemistry analyzer |
At baseline, 6 weeks and 12 weeks
|
|
Change in alanine aminotransferase (SGPT) concentration
Zeitfenster: At baseline, 6 weeks and 12 weeks
|
SGPT concentration will be determined in serum on a Clinical Chemistry analyzer |
At baseline, 6 weeks and 12 weeks
|
|
Change in gamma-glutamyl transferase (γ-GT) concentration
Zeitfenster: At baseline, 6 weeks and 12 weeks
|
γ-GT concentration will be determined in serum on a Clinical Chemistry analyzer |
At baseline, 6 weeks and 12 weeks
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in reduced glutathione concentration
Zeitfenster: At baseline, 6 weeks and 12 weeks
|
Reduced glutathione concentration will be determined in blood erythrocytes |
At baseline, 6 weeks and 12 weeks
|
|
Change in oxidized glutathione concentration
Zeitfenster: At baseline, 6 weeks and 12 weeks
|
Oxidized glutathione concentration will be determined in blood erythrocytes |
At baseline, 6 weeks and 12 weeks
|
|
Change in dietary intake
Zeitfenster: At baseline, 6 weeks and 12 weeks
|
Dietary intake habits will be assessed through dietary recalls |
At baseline, 6 weeks and 12 weeks
|
|
Change in physical activity level
Zeitfenster: At baseline, 6 weeks and 12 weeks
|
Physical activity will be assessed via accelerometry |
At baseline, 6 weeks and 12 weeks
|
|
Change in body composition
Zeitfenster: At baseline, 6 weeks and 12 weeks
|
Body composistion will be assessed via bioelectrical impedance analysis (BIA) |
At baseline, 6 weeks and 12 weeks
|
Mitarbeiter und Ermittler
Sponsor
Ermittler
- Hauptermittler: Dimitrios Draganidis, PhD, University of Thessaly
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Ernährungsstörungen
- Überernährung
- Körpergewicht
- Pathologische Zustände, Anzeichen und Symptome
- Ernährungs- und Stoffwechselerkrankungen
- Anzeichen und Symptome
- Übergewicht
- Fettleibigkeit
- Motorik
- Bewegung
- Phänomen des Bewegungsapparates muskuloskelettal
- Muskuloskelettaler und neuronales physiologisches Phänomen
- Übung
Andere Studien-ID-Nummern
- UTH_2612_8.10.2025
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .